BioLife Solutions, Inc.
BLFS
$35.07
-$0.16-0.45%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 46.91M | -14.03M | -15.67M | -3.21M | -5.53M |
| Total Depreciation and Amortization | 2.84M | 2.57M | 2.38M | 4.08M | 5.06M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -25.16M | 34.23M | 35.15M | 21.78M | 20.05M |
| Change in Net Operating Assets | -12.63M | -9.79M | -6.67M | -5.81M | -4.04M |
| Cash from Operations | 11.96M | 12.98M | 15.20M | 16.84M | 15.54M |
| Capital Expenditure | -4.89M | -5.75M | -6.01M | -6.81M | -4.68M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -4.49M | -41.58M | -66.67M | 7.77M | 9.93M |
| Cash from Investing | -9.38M | -47.33M | -72.68M | 961.00K | 5.25M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -7.50M | -7.50M | -7.50M | -10.93M | -11.14M |
| Issuance of Common Stock | 193.00K | 208.00K | 18.00K | 83.00K | 129.00K |
| Repurchase of Common Stock | -6.69M | -5.59M | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -55.00K | -451.00K | -946.00K | -1.67M | 14.00K |
| Cash from Financing | -14.05M | -13.33M | -8.43M | -12.51M | -11.00M |
| Foreign Exchange rate Adjustments | -- | -- | -- | 29.00K | 65.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -11.46M | -47.68M | -65.91M | 5.32M | 9.86M |